SCHEMBL16974624

SCHEMBL16974624

COc1cc(-c2c(C(F)(F)F)ccc(Cl)c2F)ncn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5AP P20292 1/20 0.38
▸ FEN1 P39748 1/20 0.38
▸ CYP11B2 P19099 1/20 0.37
▸ KMO O15229 2/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ MAPT P10636 1/20 0.34
▸ RAF1 P04049 2/20 0.34
▸ MAPK3 P27361 2/20 0.34
▸ GAA P10253 2/20 0.34
▸ MCOLN3 Q8TDD5 1/20 0.34
▸ FAAH O00519 2/20 0.33
▸ KDR P35968 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ MPL P40238 1/20 0.33
▸ POLB P06746 1/20 0.32
▸ PTGES O14684 1/20 0.32
▸ TSHR P16473 2/20 0.32
▸ CYP2C19 P33261 2/20 0.32
▸ USP2 O75604 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16971636 0.91 ALOX5AP (0.39) ALOX5APFEN1CYP11B2KMOMEN1
SCHEMBL16974531 0.86 KMO (0.35) ALOX5APFEN1KMOKDRPTGES
SCHEMBL16971664 0.83 UTRN (0.36) ALOX5APFEN1KMOMEN1KMT2A
SCHEMBL30271778 0.81 KMO (0.33) ALOX5APFEN1KMOKDRPTGES
SCHEMBL16971320 0.81 KMO (0.33) ALOX5APFEN1KMOKDRPTGES
SCHEMBL16971918 0.81 KMO (0.33) ALOX5APFEN1KMOKDR
SCHEMBL16971558 0.81 ALOX5AP (0.37) ALOX5APFEN1KMOKDRCYP2C19
SCHEMBL16974595 0.80 KMO (0.41) KMOFAAH
SCHEMBL16972178 0.79 GRIN1 (0.34) ALOX5APFEN1KMOKDRCYP2C19
Bromide SCHEMBL16971775 0.78 KMO (0.40) KMOFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3099686-B1 MACROCYCLES WITH AROMATIC P2' GROUPS AS FACTOR XIA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2020-03-11 — — EP disclosed
US-9777001-B2 Macrocycles with aromatic P2′ groups as factor xia inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2017-10-03 — — US disclosed
US-20170096429-A1 MACROCYCLES WITH AROMATIC P2' GROUPS AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2017-04-06 — — US disclosed
EP-3099686-A1 MACROCYCLES WITH AROMATIC P2' GROUPS AS FACTOR XIA INHIBITORS Bristol-Myers Squibb Company (US) 2016-12-07 — — EP disclosed
WO-2015116885-A1 MACROCYCLES WITH AROMATIC P2' GROUPS AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2015-08-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170096429-A1 MACROCYCLES WITH AROMATIC P2' GROUPS AS FACTOR XIA INHIBITORS TFPI, TFPI2, F2 ALOX5AP 1829/4885FEN1 3898/4885CYP11B2 2357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback